Viewpoint Molecular Targeting

US-based, early-stage pharma developing "theranostics" for metastatic melanoma

placeCoralville, Iowa, United States calendar_todayFounded 2008 groups29 employees language viewpointmt.com

Registered entities

Innovation

3 patent families — focus: Human necessities, Chemistry & metallurgy, Operations & transport; filing pace active. Cited 22 times.

YearFilings
20242
20252

Investor mix

4 investors on record.

Investor typeCountShare
Venture capital250%
Other / undisclosed250%
Coming soon